From a Molecular Biological Viewpoint, Does Endothelin Type A Receptor Antagonist Therapy Reduce Diabetes-induced Testicular Damage in Rats?
Presented at 24th European Association of Urology Congress in Stockholm, March 17-21, 2009, and selected as a best ‘andrology miscellaneous’ poster presentation.
Received 28 January 2010; accepted 16 April 2010. published online 13 July 2010.
PII: S0090-4295(10)00647-3
doi:10.1016/j.urology.2010.04.052
© 2011 Elsevier Inc. All rights reserved.
http://s7.addthis.com/js/250/addthis_widget.js#pub=xa-4b1d65bd00983246Access this article on
SciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.